Kei Oguchi

1PUBLICATIONS
1CO-AUTHORS
Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

|Oct 25, 2022
TAS2940, a novel brain-penetrable pan-ERBB inhibitor, for tumors with HER2 and EGFR aberrations.

Kei Oguchi, Hikari Araki, Shingo Tsuji

Pageof 1

Frequent Collaborators